Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179413 · ClinicalTrials.gov registry record · Phase 4
Study of Long-term Peg Intron vs. Colchicine in Non-responders.
A Phase 4 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 549
- Enrollment target
NCT00179413 is a Phase 4 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 549 participants.
The verdict
NCT00179413, a Phase 4 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 549 participants
- Enrollment target
Study Summary
In this study Peg-Intron will be tested to see if it will give better results than Colchicine. At this time, there is currently no recommended maintenance treatment for patients who have failed to respond to Interferon/Rebetron/Peg Intron and have advanced fibrosis. The purpose of this study is to compare two treatments to slow down the progression of liver disease and to prevent liver failure and liver cancer. The treatment will not cure Hepatitis C, but is being evaluated to see if it can slow down disease progression.
Interventions
- DRUG Colchicine
- DRUG PEG -Intron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 549 participants |
| Start Date | 2000-01-15 |
| Est. Completion | 2010-03-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179413
The ClinicalTrials.gov registry entry for NCT00179413 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 549 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Colchicine is the first listed.
NCT00179413 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00179413 about?
NCT00179413 is a clinical study titled "Study of Long-term Peg Intron vs. Colchicine in Non-responders.". In this study Peg-Intron will be tested to see if it will give better results than Colchicine. At this time, there is currently no recommended maintenance treatment for patients who have failed to respond to Interferon/Rebetron/Peg Intron and have advanced fibrosis. The purpose of this study is to c...
What is the current status of trial NCT00179413?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 549 participants. The study started on 2000-01-15. Estimated completion is 2010-03-03.
What interventions are being tested in trial NCT00179413?
The interventions under investigation include: Colchicine (DRUG), PEG -Intron (DRUG).
Who is sponsoring clinical trial NCT00179413?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.